These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 16885549)

  • 1. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus.
    Babenko AP; Polak M; Cavé H; Busiah K; Czernichow P; Scharfmann R; Bryan J; Aguilar-Bryan L; Vaxillaire M; Froguel P
    N Engl J Med; 2006 Aug; 355(5):456-66. PubMed ID: 16885549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
    Pearson ER; Flechtner I; Njølstad PR; Malecki MT; Flanagan SE; Larkin B; Ashcroft FM; Klimes I; Codner E; Iotova V; Slingerland AS; Shield J; Robert JJ; Holst JJ; Clark PM; Ellard S; Søvik O; Polak M; Hattersley AT;
    N Engl J Med; 2006 Aug; 355(5):467-77. PubMed ID: 16885550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of two KCNJ11 neonatal diabetes mutations, V59G and V59A, and the analogous KCNJ8 I60G substitution: differences between the channel subtypes formed with SUR1.
    Winkler M; Lutz R; Russ U; Quast U; Bryan J
    J Biol Chem; 2009 Mar; 284(11):6752-62. PubMed ID: 19139106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased ATPase activity produced by mutations at arginine-1380 in nucleotide-binding domain 2 of ABCC8 causes neonatal diabetes.
    de Wet H; Rees MG; Shimomura K; Aittoniemi J; Patch AM; Flanagan SE; Ellard S; Hattersley AT; Sansom MS; Ashcroft FM
    Proc Natl Acad Sci U S A; 2007 Nov; 104(48):18988-92. PubMed ID: 18025464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes.
    Proks P; Arnold AL; Bruining J; Girard C; Flanagan SE; Larkin B; Colclough K; Hattersley AT; Ashcroft FM; Ellard S
    Hum Mol Genet; 2006 Jun; 15(11):1793-800. PubMed ID: 16613899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel ABCC8 (SUR1)-dependent mechanism of metabolism-excitation uncoupling.
    Babenko AP
    J Biol Chem; 2008 Apr; 283(14):8778-82. PubMed ID: 18281290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfonylurea receptor 1 mutations that cause opposite insulin secretion defects with chemical chaperone exposure.
    Pratt EB; Yan FF; Gay JW; Stanley CA; Shyng SL
    J Biol Chem; 2009 Mar; 284(12):7951-9. PubMed ID: 19151370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New ABCC8 mutations in relapsing neonatal diabetes and clinical features.
    Vaxillaire M; Dechaume A; Busiah K; Cavé H; Pereira S; Scharfmann R; de Nanclares GP; Castano L; Froguel P; Polak M;
    Diabetes; 2007 Jun; 56(6):1737-41. PubMed ID: 17389331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a novel missense mutation, p.P1199L, in the ABCC8 gene.
    Oztekin O; Durmaz E; Kalay S; Flanagan SE; Ellard S; Bircan I
    J Perinatol; 2012 Aug; 32(8):645-7. PubMed ID: 22842804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP-sensitive potassium channels--neonatal diabetes mellitus and beyond.
    Sperling MA
    N Engl J Med; 2006 Aug; 355(5):507-10. PubMed ID: 16885555
    [No Abstract]   [Full Text] [Related]  

  • 11. Heterozygous ABCC8 mutations are a cause of MODY.
    Bowman P; Flanagan SE; Edghill EL; Damhuis A; Shepherd MH; Paisey R; Hattersley AT; Ellard S
    Diabetologia; 2012 Jan; 55(1):123-7. PubMed ID: 21989597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permanent neonatal diabetes due to activating mutations in ABCC8 and KCNJ11.
    Edghill EL; Flanagan SE; Ellard S
    Rev Endocr Metab Disord; 2010 Sep; 11(3):193-8. PubMed ID: 20922570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood.
    Flanagan SE; Patch AM; Mackay DJ; Edghill EL; Gloyn AL; Robinson D; Shield JP; Temple K; Ellard S; Hattersley AT
    Diabetes; 2007 Jul; 56(7):1930-7. PubMed ID: 17446535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes.
    Masia R; Koster JC; Tumini S; Chiarelli F; Colombo C; Nichols CG; Barbetti F
    Diabetes; 2007 Feb; 56(2):328-36. PubMed ID: 17259376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of the same conserved glutamate residue in NBD2 of the sulfonylurea receptor 1 subunit of the KATP channel can result in either hyperinsulinism or neonatal diabetes.
    Männikkö R; Flanagan SE; Sim X; Segal D; Hussain K; Ellard S; Hattersley AT; Ashcroft FM
    Diabetes; 2011 Jun; 60(6):1813-22. PubMed ID: 21617188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations.
    Rafiq M; Flanagan SE; Patch AM; Shields BM; Ellard S; Hattersley AT;
    Diabetes Care; 2008 Feb; 31(2):204-9. PubMed ID: 18025408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the ABCC8 gene encoding the SUR1 subunit of the KATP channel cause transient neonatal diabetes, permanent neonatal diabetes or permanent diabetes diagnosed outside the neonatal period.
    Patch AM; Flanagan SE; Boustred C; Hattersley AT; Ellard S
    Diabetes Obes Metab; 2007 Nov; 9 Suppl 2(Suppl 2):28-39. PubMed ID: 17919176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rare mutation in ABCC8/SUR1 leading to altered ATP-sensitive K+ channel activity and beta-cell glucose sensing is associated with type 2 diabetes in adults.
    Tarasov AI; Nicolson TJ; Riveline JP; Taneja TK; Baldwin SA; Baldwin JM; Charpentier G; Gautier JF; Froguel P; Vaxillaire M; Rutter GA
    Diabetes; 2008 Jun; 57(6):1595-604. PubMed ID: 18346985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permanent neonatal diabetes caused by dominant, recessive, or compound heterozygous SUR1 mutations with opposite functional effects.
    Ellard S; Flanagan SE; Girard CA; Patch AM; Harries LW; Parrish A; Edghill EL; Mackay DJ; Proks P; Shimomura K; Haberland H; Carson DJ; Shield JP; Hattersley AT; Ashcroft FM
    Am J Hum Genet; 2007 Aug; 81(2):375-82. PubMed ID: 17668386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal diabetes caused by mutations in sulfonylurea receptor 1: interplay between expression and Mg-nucleotide gating defects of ATP-sensitive potassium channels.
    Zhou Q; Garin I; Castaño L; Argente J; Muñoz-Calvo MT; Perez de Nanclares G; Shyng SL
    J Clin Endocrinol Metab; 2010 Dec; 95(12):E473-8. PubMed ID: 20810569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.